眼科抗VEGF治疗的进展和新兴趋势:一个图书统计分析
1The First Clinical College of Traditional Chinese Medicine, Hunan University of Traditional Chinese Medicine, Changsha, Hunan, China.
International ophthalmology
|September 5, 2024
概括
抗VEGF药物对于治疗新血管眼病至关重要,在临床试验中显示出成功. 未来的研究将专注于新药开发和药物输送系统,以改善患者的治疗结果.
科学领域:
- 眼科医生 眼科 眼科
- 医学研究 医学研究
- 生物技术是生物技术.
背景情况:
- 血管内皮生长因子 (VEGF) 驱动异常 fundus 新血管化.
- 抗VEGF药物对于治疗新血管眼病至关重要.
- 20年来对抗VEGF在眼科中的应用进行了审查,提供了研究见解.
研究的目的:
- 审查在眼科中使用抗VEGF药物的应用.
- 为未来对抗VEGF治疗的研究提供见解.
- 分析关于反VEGF研究的文献数据.
主要方法:
- 从科学网络上对3,602篇出版物 (2003-2023) 的图书统计分析.
- 使用VOSviewer,CiteSpace和R包Bibliometrix进行文献分析.
- 包括来自83个国家和3445个机构的数据.
主要成果:
- 美国和中国在出版物方面处于领先地位;约翰霍普金斯大学,悉尼大学和Genentech Inc是关键机构.
- "视网膜"和"眼科"是著名的研究领域.
- 高频关键词包括"内皮生长因子"",治疗"",安全"和"随机临床试验".
结论:
- 抗VEGF药物在治疗湿与年龄相关的黄斑变性和糖尿病黄斑胀方面取得了成功.
- 未来的方向包括新药开发,先进的输送系统和AI集成.
- 持续的创新旨在实现更有效,更安全,更经济的眼睛疾病治疗.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Open Angle Glaucoma: Treatment
408
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
408
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


